The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...
TOKYO & MUNICH, January 19, 2026--(BUSINESS WIRE)--The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in ...
ABB has released its ACS880 Virtual DrivePlus. This high-fidelity software-in-the-loop (SIL) system runs low-voltage drive control firmware to ensure accurate simulation of a drive’s behavior, ...
IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. This glossary will help you grasp the vocabulary behind the technology of drones, so that you can ...
The FDA has prioritized reviewing Padcev and Keytruda for MIBC patients ineligible for cisplatin chemotherapy, with a target action date of April 7, 2026. Phase 3 EV-303 trial results showed a 60% ...
ABSTRACT: SQL injection attacks pose a critical threat to web application security, exploiting vulnerabilities to gain access, or modify sensitive data. Traditional rule-based and machine learning ...
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (PSTV) (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...
"I’ve developed a text-to-SQL application using Gemini, which converts natural language input into SQL queries. By leveraging the power of Gemini, the application efficiently understands and processes ...
The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. The FDA accepted a supplemental new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results